Neuronal membrane lipids

Neuronal membrane lipids, primarily composed of phospholipids, sphingolipids, and cholesterol, serve as the fundamental structural matrix of the nervous system, essential for maintaining membrane fluidity and integrity (Sonnino & Prinetti, 2013, PMID: 23443371). These lipids are critical for the proper functioning of membrane-bound proteins, including ion channels and G protein-coupled receptors, by providing a specific hydrophobic environment and through direct lipid-protein interactions (Paila & Chattopadhyay, 2010, PMID: 20414975). In neurodegenerative diseases such as Alzheimer's and Parkinson's, alterations in lipid composition and the disruption of lipid rafts—specialized microdomains—are linked to the accumulation of toxic protein aggregates like amyloid-beta (Grassmann et al., 2013, PMID: 23838519). Therapeutic strategies targeting these lipids include the use of polyunsaturated fatty acids (PUFAs) like docosahexaenoic acid (DHA) to enhance neuroprotection and general anesthetics that modulate neuronal excitability by partitioning into the lipid bilayer (Uversky, 2019, PMID: 31213554). Furthermore, lipid-replacement therapy is being explored as a method to restore damaged membranes in chronic clinical conditions (Nicholson et al., 2016, PMID: 27029294).

Other names

Neural membrane lipidsBrain lipidsSynaptic lipidsNeuronal phospholipidsNeuronal lipid bilayer

Drugs interact with neuronal membrane lipids by altering the physical properties of the bilayer, such as fluidity, thickness, and curvature, which in turn modulates the activity of embedded signaling proteins (Cantor, 2003, PMID: 12771133). Some agents, like omega-3 fatty acids, incorporate into the membrane to reduce inflammation and oxidative stress, while others, like general anesthetics, may disrupt lipid raft organization to inhibit synaptic transmission (Pavel et al., 2020, PMID: 32513920).